News
On Thursday, HSBC (LON:HSBA) analysts upgraded CSPC Pharmaceutical (TADAWUL:2070) Group Ltd. (1093:HK) (OTC:CHJTF) stock rating from Hold to Buy. The upgrade is accompanied by a new price target of ...
On Thursday, HSBC analysts upgraded CSPC Pharmaceutical Group Ltd. (1093:HK) (OTC:CHJTF) stock rating from Hold to Buy. The upgrade is accompanied by a new price target of HK$9.50, up from the ...
On Monday, CSPC Pharmaceutical Group Ltd. (1093:HK) (OTC:CHJTF) received a downgrade in its stock rating from Jefferies, moving from Hold to Underperform. The firm also adjusted the price target ...
CSPC Pharma was already on track for a tough earnings season after its nine-month profits fell 15.9% Another blow was the sudden departure of the firm's head of innovative drug research, Liu ...
CSPC Pharmaceutical Group Ltd. ADR Quarterly stock financials by MarketWatch. View the latest CSPCY financial statements, income statements and financial ratios. Skip to main content ...
CSPC Pharmaceutical Group (HK:1093) has released an update. Don't Miss Our New Year's Offers: Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top ...
Overview: CSPC Innovation Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of biopharmaceuticals, APIs, and functional foods both in China and internationally ...
Here we highlight a subset of our preferred stocks from the screener. Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development ...
CSPC Pharmaceutical Group Limited has announced the resignation of Dr. Jiang Hao as Executive Director, with Mr. Chen Weiping stepping into the role. Mr. Chen, a seasoned leader within the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results